Barclays »

Vyne Therapeutics shares owned by Barclays

Quarter-by-quarter ownership of Vyne Therapeutics (VYNE) shares owned by Barclays from 13F filings

Historical chart of Barclays investment in Vyne Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Vyne Therapeutics held by Barclays consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Vyne Therapeutics by Barclays

Quarter filed Position value Share count Share price at filing
2026-06-30 $92 141 0.65
2024-09-30 $0 100 0.00

More positions owned by Barclays

STATE STR SPDR S&ampP 500 ETF T Fund (SPY)
Ishares Tr Opt Call Option (EEM)
Microsoft Corp Opt Call Option (MSFT)
Invesco Qqq Tr Fund (QQQ)
Ishares Tr Fund (IWM)
Nvidia Corporation Opt Call Option (NVDA)
Micron Technology (MU)
Apple (AAPL)
Alphabet Inc Class A cs (GOOGL)
Amazon Opt Put Option (AMZN)
Vaneck Etf Trust Opt Put Option (SMH)
Tesla Motors (TSLA)
Advanced Micro Devices Opt Put Option (AMD)
Broadcom Opt Put Option (AVGO)
Ishares Tr Opt Call Option (HYG)

View all positions for Barclays

Top funds holding Vyne Therapeutics

ADAR1 Capital Management
Nantahala Capital Management
Lynx1 Capital Management
Shay Capital
T3 Companies
Braidwell
KVP Capital Advisors
Citadel Advisors
Two Sigma Investments
Acadian Asset Management
Ikarian Capital
Vanguard Capital Management
Geode Capital Management
Vanguard Fiduciary Trust
Susquehanna International

View all funds holding Vyne Therapeutics